184 related articles for article (PubMed ID: 15145934)
1. Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis.
Lefevre G; Glotin AL; Calipel A; Mouriaux F; Tran T; Kherrouche Z; Maurage CA; Auclair C; Mascarelli F
J Biol Chem; 2004 Jul; 279(30):31769-79. PubMed ID: 15145934
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.
Calipel A; Landreville S; De La Fouchardière A; Mascarelli F; Rivoire M; Penel N; Mouriaux F
Clin Exp Metastasis; 2014 Jun; 31(5):553-64. PubMed ID: 24652072
[TBL] [Abstract][Full Text] [Related]
3. c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
Smalley KS; Sondak VK; Weber JS
Histol Histopathol; 2009 May; 24(5):643-50. PubMed ID: 19283671
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
[TBL] [Abstract][Full Text] [Related]
5. c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?
All-Ericsson C; Girnita L; Müller-Brunotte A; Brodin B; Seregard S; Ostman A; Larsson O
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2075-82. PubMed ID: 15223779
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling.
Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW
Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010
[TBL] [Abstract][Full Text] [Related]
7. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
8. The stem cell factor-c-kit system and mast cells in human pancreatic cancer.
Esposito I; Kleeff J; Bischoff SC; Fischer L; Collecchi P; Iorio M; Bevilacqua G; Büchler MW; Friess H
Lab Invest; 2002 Nov; 82(11):1481-92. PubMed ID: 12429808
[TBL] [Abstract][Full Text] [Related]
9. Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells.
Calipel A; Mouriaux F; Glotin AL; Malecaze F; Faussat AM; Mascarelli F
J Biol Chem; 2006 Apr; 281(14):9238-50. PubMed ID: 16452469
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas.
Reis RM; Martins A; Ribeiro SA; Basto D; Longatto-Filho A; Schmitt FC; Lopes JM
Cell Oncol; 2005; 27(5-6):319-26. PubMed ID: 16373964
[TBL] [Abstract][Full Text] [Related]
11. STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1.
Jin T; Nakatani H; Taguchi T; Nakano T; Okabayashi T; Sugimoto T; Kobayashi M; Araki K
World J Gastroenterol; 2006 Feb; 12(5):703-8. PubMed ID: 16521182
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
[TBL] [Abstract][Full Text] [Related]
13. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
14. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
15. Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report.
Rapisuwon S; Parks K; Al-Refaie W; Atkins MB
Melanoma Res; 2014 Oct; 24(5):509-11. PubMed ID: 25003536
[TBL] [Abstract][Full Text] [Related]
16. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.
Frost MJ; Ferrao PT; Hughes TP; Ashman LK
Mol Cancer Ther; 2002 Oct; 1(12):1115-24. PubMed ID: 12481435
[TBL] [Abstract][Full Text] [Related]
17. c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes.
Monsel G; Ortonne N; Bagot M; Bensussan A; Dumaz N
Oncogene; 2010 Jan; 29(2):227-36. PubMed ID: 19802003
[TBL] [Abstract][Full Text] [Related]
18. [The diagnostic and predictive role of kit (CD117)].
Dirnhofer S; Zimpfer A; Went P
Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
[TBL] [Abstract][Full Text] [Related]
19. The effect of imatinib mesylate (Glivec) on human tumor-derived cells.
Knight LA; Di Nicolantonio F; Whitehouse PA; Mercer SJ; Sharma S; Glaysher S; Hungerford JL; Hurren J; Lamont A; Cree IA
Anticancer Drugs; 2006 Jul; 17(6):649-55. PubMed ID: 16917210
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.
Moses AV; Jarvis MA; Raggo C; Bell YC; Ruhl R; Luukkonen BG; Griffith DJ; Wait CL; Druker BJ; Heinrich MC; Nelson JA; Früh K
J Virol; 2002 Aug; 76(16):8383-99. PubMed ID: 12134042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
